Arterial occlusion after cessation of warfarin treatment

Yıl 2020, Cilt: 45 Sayı: 1, 381 - 382, 31.03.2020

Hatice Şeyma Akça Abdullah Algın Hayrullah Yönak Serkan Emre Eroğlu

https://doi.org/10.17826/cumj.650126

Cited By: 1

Öz

-

Anahtar Kelimeler

warfarin, arterial occlusion

Warfarin tedavisinin kesilmesi sonrasında görülen arteryal oklüzyon

Öz

-

Anahtar Kelimeler

warfarin, arterial occlusion

Kaynakça

• 1.L Grip, M Blomback, S Schulman, Hypercoagulable state and thromboembolism following warfarin with drawal in post-myocardial-infarction patients,European Heart Journal 1991 (12);11:1225-33.
• 2. Yu HY, Tsai HE, Chen YS, Hung KY, Comparison of warfarin dosage fluctuation with time in therapeutic range for bleeding or thromboembolism rate in Chinese patients, Journal of the Formosan Medical Association 2019 (118);2:611-8. Doi: 10.1016/j.jfma.2018.07.021.
• 3. Carter SA, McDevitt E, Gatje BW, Wright IS, Analysis of factors affecting the recurrence of thromboembolism off and on anticoagulant therapy. Am J Med 1958(25);1:43-51. Doi:10.1016/0002-9343(58)90197-9.
• 4.Van Cleve RB, Letting go of the Bear's Tail. Experience with discontinuation of long-term anticoagulant therapy JAMA 1966(196);13:1156-8. Doi:10.1001/jama.196.13.1156.
• 5.Breddin HK, Krzywanek HJ, Althoff P, Kirshmaier CM, Rosak C, Schepping M et al. Haemostasiological parameters as risk factor for new arterial occlusions in diabetics. KlinWochenschr 1986(64);20:1042-6.
• 6. Roy MS, Podgor MJ, Rick ME, Plasma fibrinopeptide A, beta thromboglobulin, and platelet factor 4 in diabetic retinopathy. Invest Ophthalmol Vis Sci 1988(29);6:856-60.
• 7. Small M, Lowe GDO, MacCuish AC, Forbes CD, Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic control. Q J Med 1987(65);248:1025-31.
• 8.Ishii M, Kameyama M, Inokuchi T, Isogai S, Plasma fibrinopeptide A levels during insulin-induced plasma glucosefalls in diabetics. DiabetesResClinPract 1987(4);1:45-50. Doi:10.1016/s0168-8227(87)80032-3.
• 9. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE, Acetaminophen and other risk factors for excessive warfarin anticoagulation.JAMA, 1998(279);9:657-62. Doi:10.1001/jama.279.9.657.
• 10. Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, et al.Can we predict daily adherence to warfarin? : Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study, Chest, 2010(137);4:883-9. doi: 10.1378/chest.09-0039.